These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 29721567

  • 1. The kinetics of dimethylhydroxypyridinone interactions with iron(iii) and the catalysis of iron(iii) ligand exchange reactions: implications for bacterial iron transport and combination chelation therapies.
    Harrington JM, Mysore MM, Crumbliss AL.
    Dalton Trans; 2018 May 22; 47(20):6954-6964. PubMed ID: 29721567
    [Abstract] [Full Text] [Related]

  • 2. Factors that influence siderophoremediated iron bioavailability: catalysis of interligand iron (III) transfer from ferrioxamine B to EDTA by hydroxamic acids.
    Monzyk B, Crumbliss AL.
    J Inorg Biochem; 1983 Aug 22; 19(1):19-39. PubMed ID: 6413650
    [Abstract] [Full Text] [Related]

  • 3. Carrier-facilitated bulk liquid membrane transport of iron(III)-siderophore complexes utilizing first coordination sphere recognition.
    Wirgau JI, Crumbliss AL.
    Inorg Chem; 2003 Sep 08; 42(18):5762-70. PubMed ID: 12950227
    [Abstract] [Full Text] [Related]

  • 4. Biologically active thiosemicarbazone Fe chelators and their reactions with ferrioxamine B and ferric EDTA; a kinetic study.
    Bernhardt PV, Martínez M, Rodríguez C, Vazquez M.
    Dalton Trans; 2012 Feb 21; 41(7):2122-30. PubMed ID: 22180864
    [Abstract] [Full Text] [Related]

  • 5. Tripodal peptide hydroxamates as siderophore models. Iron(III) binding with ligands containing H-(alanyl)n-beta-(N-hydroxy)alanyl strands (n = 1-3) anchored by nitrilotriacetic acid.
    Hara Y, Shen L, Tsubouchi A, Akiyama M, Umemoto K.
    Inorg Chem; 2000 Oct 30; 39(22):5074-82. PubMed ID: 11233204
    [Abstract] [Full Text] [Related]

  • 6. Ternary complex formation facilitates a redox mechanism for iron release from a siderophore.
    Mies KA, Wirgau JI, Crumbliss AL.
    Biometals; 2006 Apr 30; 19(2):115-26. PubMed ID: 16718598
    [Abstract] [Full Text] [Related]

  • 7. Coordination chemistry and biology of chelators for the treatment of iron overload disorders.
    Bernhardt PV.
    Dalton Trans; 2007 Aug 14; (30):3214-20. PubMed ID: 17893764
    [Abstract] [Full Text] [Related]

  • 8. Thermo-FTIR spectroscopic study of the siderophore ferrioxamine B: spectral analysis and stereochemical implications of iron chelation, pH, and temperature.
    Siebner-Freibach H, Yariv S, Lapides Y, Hadar Y, Chen Y.
    J Agric Food Chem; 2005 May 04; 53(9):3434-43. PubMed ID: 15853384
    [Abstract] [Full Text] [Related]

  • 9. Ferrioxamine B analogues: targeting the FoxA uptake system in the pathogenic Yersinia enterocolitica.
    Kornreich-Leshem H, Ziv C, Gumienna-Kontecka E, Arad-Yellin R, Chen Y, Elhabiri M, Albrecht-Gary AM, Hadar Y, Shanzer A.
    J Am Chem Soc; 2005 Feb 02; 127(4):1137-45. PubMed ID: 15669853
    [Abstract] [Full Text] [Related]

  • 10. Iron chelators for clinical use.
    Tilbrook GS, Hider RC.
    Met Ions Biol Syst; 1998 Feb 02; 35():691-730. PubMed ID: 9444773
    [No Abstract] [Full Text] [Related]

  • 11. Kinetics of iron release from ferric binding protein (FbpA): mechanistic implications in bacterial periplasm-to-cytosol Fe3+ transport.
    Dhungana S, Anderson DS, Mietzner TA, Crumbliss AL.
    Biochemistry; 2005 Jul 19; 44(28):9606-18. PubMed ID: 16008346
    [Abstract] [Full Text] [Related]

  • 12. Acyclonucleoside iron chelators of 1-(2-hydroxyethoxy)methyl-2-alkyl-3-hydroxy-4-pyridinones: potential oral iron chelation therapeutics.
    Liu G, Men P, Kenner GH, Miller SC, Bruenger FW.
    Nucleosides Nucleotides Nucleic Acids; 2004 Jul 19; 23(3):599-611. PubMed ID: 15113026
    [Abstract] [Full Text] [Related]

  • 13. Synthetic, potentiometric and spectroscopic studies of chelation between Fe(III) and 2,5-DHBA supports salicylate-mode of siderophore binding interactions.
    Porwal SK, Furia E, Harris ME, Viswanathan R, Devireddy L.
    J Inorg Biochem; 2015 Apr 19; 145():1-10. PubMed ID: 25589161
    [Abstract] [Full Text] [Related]

  • 14. A new approach for potential combined chelation therapy using mono- and bis-hydroxypyridinones.
    Santos MA, Gama S, Gil M, Gano L.
    Hemoglobin; 2008 Apr 19; 32(1-2):147-56. PubMed ID: 18274992
    [Abstract] [Full Text] [Related]

  • 15. Chelator-facilitated removal of iron from transferrin: relevance to combined chelation therapy.
    Devanur LD, Evans RW, Evans PJ, Hider RC.
    Biochem J; 2008 Jan 15; 409(2):439-47. PubMed ID: 17919118
    [Abstract] [Full Text] [Related]

  • 16. Multidentate pyridinones inhibit the metabolism of nontransferrin-bound iron by hepatocytes and hepatoma cells.
    Chua AC, Ingram HA, Raymond KN, Baker E.
    Eur J Biochem; 2003 Apr 15; 270(8):1689-98. PubMed ID: 12694182
    [Abstract] [Full Text] [Related]

  • 17. Cyclic Hydroxamic Acid Analogues of Bacterial Siderophores as Iron-Complexing Agents prepared through the Castagnoli-Cushman Reaction of Unprotected Oximes.
    Bakulina O, Bannykh A, Dar'in D, Krasavin M.
    Chemistry; 2017 Dec 14; 23(70):17667-17673. PubMed ID: 29072340
    [Abstract] [Full Text] [Related]

  • 18. New chelate-forming polymer microspheres carrying dyes as chelators for iron overload.
    Denizli A, Salih B, Piskin E.
    J Biomater Sci Polym Ed; 1998 Dec 14; 9(2):175-87. PubMed ID: 9493844
    [Abstract] [Full Text] [Related]

  • 19. Ethical issues and risk/benefit assessment of iron chelation therapy: advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox.
    Kontoghiorghes GJ.
    Hemoglobin; 2008 Dec 14; 32(1-2):1-15. PubMed ID: 18274978
    [Abstract] [Full Text] [Related]

  • 20. The role of iron and chelators on infections in iron overload and non iron loaded conditions: prospects for the design of new antimicrobial therapies.
    Kontoghiorghes GJ, Kolnagou A, Skiada A, Petrikkos G.
    Hemoglobin; 2010 Jun 14; 34(3):227-39. PubMed ID: 20524813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.